BioRestorative reduces authorized shares to 75M after 1-for-4,000 reverse split

BioRestorative Therapies, Inc.

Board approved reduction of authorized common shares from 300B to 75M, consistent with the 1-for-4,000 reverse split ratio.
Certificate of Amendment filed with Delaware Secretary of State on November 16, 2021; effective immediately.
Reverse split was previously effected on October 27, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.